Single-dose pharmacokinetics of levofloxacin during continuous veno-venous haemofiltration in critically ill patients

J Antimicrob Chemother. 2001 Feb;47(2):229-31. doi: 10.1093/jac/47.2.229.

Abstract

The present study was performed to analyse the pharmacokinetics of levofloxacin during continuous veno-venous haemofiltration (CVVH) with a high-flux polyamide membrane. Twelve patients received 500 mg levofloxacin intravenously. The mean levofloxacin concentration peak was 1.9 +/- 1.0 mg/L. The elimination half-life, haemofiltration clearance and total removal were 8.3 +/- 2.6 h, 27.6 +/- 8.4 mL/min and 56 +/- 19%, respectively. Further multiple-dose studies are required to enable dosage recommendations to be made for patients receiving renal replacement therapy with CVVH.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents / pharmacokinetics*
  • Area Under Curve
  • Chromatography, High Pressure Liquid
  • Critical Care*
  • Female
  • Half-Life
  • Hemofiltration*
  • Humans
  • Injections, Intravenous
  • Levofloxacin*
  • Male
  • Middle Aged
  • Ofloxacin / pharmacokinetics*

Substances

  • Anti-Infective Agents
  • Levofloxacin
  • Ofloxacin